Lymphangioma, anys site

CD2_BENIGN_LYMPHANGIOMA

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 D18.1&
  • Hospital discharge: ICD-9 2281
  • Hospital discharge: ICD-8 22701
  • Cause of death: ICD-10 D18.1&
  • Cause of death: ICD-9 2281
  • Cause of death: ICD-8 22701

2 out of 7 registries used, show all original rules.

318

4. Check minimum number of events

None

318

5. Include endpoints

None

318

6. Filter based on genotype QC (FinnGen only)

296

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D18
Name in latin
Lymphangioma (quovis hoco)

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2976 1458 1511
Only index persons 2551 1253 1298
Unadjusted period prevalence (%)
Whole population 0.04 0.04 0.04
Only index persons 0.05 0.05 0.05
Median age at first event (years)
Whole population 16.06 17.67 14.29
Only index persons 18.56 20.72 16.47

-FinnGen-

Key figures

All Female Male
Number of individuals 296 181 115
Unadjusted period prevalence (%) 0.06 0.06 0.05
Median age at first event (years) 34.14 36.34 30.67

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
300
Matched controls
3000
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D18.1
ICD-10 Finland
Lymphangioma, any site
12011.1
307.3
241
*
D18.0
ICD-10 Finland
Haemangioma, any site
21.5
69.7
55
31
2281A
ICD-9 Finland
Haemangioma and lymphangioma, any site, Lymphangioma, any site
+∞
38.4
36
*
22701
ICD-8 Finland
Haemangioma and lymphangioma, Lymphangioma
+∞
38.4
36
*
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
9.5
32.5
41
49
QX3LT
NOMESCO Finland
Subcutaneous sclerotherapy
202.1
18.8
19
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
15.1
103
470
EP1LT
NOMESCO Finland
Percutaneous sclerotherapy of vascular malformation of head and neck
+∞
14.7
14
*
Q27.4
ICD-10 Finland
Congenital phlebectasia
157.3
14.6
15
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.1
12.9
23
40
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
17.3
11.8
18
11
Q27.9
ICD-10 Finland
Congenital malformation of peripheral vascular system, unspecified
113.8
10.5
11
*
22700
ICD-8 Finland
Haemangioma and lymphangioma, Haemangioma
56.9
9.7
11
*
XX6KT
NOMESCO Finland
Other sclerotherapy
37.9
9.1
11
*
Q18.0
ICD-10 Finland
Sinus, fistula and cyst of branchial cleft
14.6
8.8
14
10
J01CE08
ATC
benzathine benzylpenicillin; parenteral
16.9
8.6
13
8
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
8.9
8.4
17
20
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
8.2
115
692
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
7.7
119
737
Q27.88
ICD-10 Finland
Other specified congenital malformation of peripheral vascular system
82.0
7.4
8
*
4704
FHL
Neck tumor removal
82.0
7.4
8
*
9736
FHL
Subcutaneous tumor removal in operating room or anesthesia
13.8
7.4
12
9
EP1AT
NOMESCO Finland
Punction of soft tissue of neck with ultrasound guidance
+∞
7.3
7
*
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
30.8
7.2
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
6.8
72
386
S04
ICPC
Lump/swelling localized
2.5
6.8
47
210
ENB40
NOMESCO Finland
Excision of branchial cyst or fistula
23.1
6.7
9
*
Q18.8
ICD-10 Finland
Other specified congenital malformations of face and neck
71.3
6.4
7
*
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
71.3
6.4
7
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
6.4
45
202
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
18.5
6.3
9
5
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.7
6.3
20
57

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
98
600
1.94
6.35
3.8
4.3
—
—
—
0
0
120
820
1.77
5.31
2.5
2.3
—
—
—
0
0
134
955
1.73
5.05
2.3
2.0
—
—
—
0
0
159
1195
1.70
4.88
2.7
2.8
—
—
estimate
—
0
0
131
949
1.68
4.52
9.6
11.3
1.13
1.18
inr
0.76
117
785
10
15
6.85
4.50
1.1
1.6
9.47
10.43
umol/l
—
10
15
186
1516
1.60
3.72
11.3
10.1
3.88
3.97
e9/l
0.30
169
1318
94
653
1.64
3.67
7.4
4.7
95.16
90.81
%
1.27
94
642
218
1853
1.65
3.60
9.5
7.8
87.43
80.96
u/l
0.42
212
1751
35
186
2.00
3.32
1.3
1.4
—
—
—
0
0
149
1175
1.53
3.29
9.0
7.9
1.20
1.22
mmol/l
1.49
133
1023
34
183
1.97
3.12
5.2
4.5
7.32
7.34
ph
0.18
24
127
13
41
3.27
3.10
1.3
1.3
—
—
—
0
0
36
199
1.92
3.06
3.6
4.8
0.46
0.40
%
0.10
13
59
107
798
1.53
3.00
6.1
6.2
—
—
—
0
0
142
1129
1.49
2.91
2.9
2.7
77.28
73.87
nmol/l
0.74
135
1037
167
1373
1.49
2.89
7.7
6.6
0.57
0.55
e9/l
0.49
156
1185
167
1378
1.48
2.80
7.7
6.6
0.04
0.04
e9/l
0.08
156
1185
170
1415
1.46
2.68
7.7
6.6
1.88
2.07
e9/l
0.75
161
1261
49
316
1.66
2.51
1.3
1.3
—
—
—
0
0
13
52
2.57
2.39
1.5
1.3
6.20
3.64
u/ml
—
5
22
13
52
2.57
2.39
1.2
1.0
—
—
—
0
0
48
314
1.63
2.33
1.4
1.2
—
—
—
0
0
12
47
2.62
2.30
1.3
1.1
—
—
—
0
0
34
205
1.74
2.23
4.8
3.9
5.34
10.43
ug/l
0.74
28
162
33
198
1.75
2.20
4.1
5.0
0.10
0.13
%
—
10
53
34
207
1.72
2.16
4.1
5.2
0.00
0.20
%
0.74
11
55
8
25
3.26
2.11
1.4
1.4
—
—
—
0
0
167
1428
1.38
2.04
8.0
6.9
0.20
0.19
e9/l
0.57
158
1259
24
136
1.83
1.94
9.5
5.2
—
—
—
0
0
111
894
1.38
1.93
8.0
7.0
—
—
—
0
0
77
582
1.43
1.92
3.4
2.3
2.02
1.30
mg/l
0.36
62
455
20
108
1.91
1.86
1.2
1.2
—
—
—
0
0
44
298
1.56
1.86
7.0
8.6
105.07
104.47
mmol/l
0.35
44
298
13
60
2.22
1.80
1.2
1.1
—
—
—
0
0
84
653
1.40
1.78
4.3
4.5
—
—
—
0
0
15
74
2.08
1.78
1.3
1.4
274.17
294.53
ug/g
—
6
42
6
18
3.38
1.75
4.2
1.7
1232.50
938.94
mg
—
6
18
41
280
1.54
1.68
3.3
5.8
7.37
7.38
ph
0.39
29
167
33
214
1.61
1.68
4.1
4.8
0.50
0.76
%
—
10
69
127
1063
1.34
1.68
8.6
7.8
1.20
1.22
mmol/l
1.83
117
983
44
307
1.51
1.64
1.6
1.5
—
—
—
0
0
36
245
1.53
1.51
7.3
11.2
0.35
0.59
mmol/l
0.13
28
201
6
21
2.89
1.51
1.2
1.3
—
—
—
0
0
29
189
1.59
1.46
2.5
3.9
62.41
73.48
e9/l
1.52
22
135
5
17
2.97
1.36
1.2
1.1
—
—
—
0
0
5
17
2.97
1.36
1.4
1.1
—
—
—
0
0
154
1352
1.29
1.36
3.8
3.0
78.53
90.37
ug/l
0.53
149
1276
10
47
2.17
1.35
4.9
2.2
5.39
5.07
kpa
—
10
47
10
47
2.17
1.35
4.9
2.2
9.37
8.74
kpa
—
10
47
46
340
1.42
1.30
1.9
2.1
—
—
—
0
0
5
18
2.81
1.29
1.0
1.0
—
—
—
0
0
9
44
2.08
1.28
4.1
2.3
—
—
—
0
0
38
272
1.45
1.27
3.4
5.8
1.77
1.49
mmol/l
0.18
32
221
9
45
2.03
1.24
1.3
2.1
4.92
7.43
pmol/l
—
9
45
16
93
1.76
1.24
6.8
3.3
313.56
258.67
mg/l
—
9
40
162
1443
1.27
1.23
5.9
5.6
6.29
6.49
mmol/l
0.86
156
1337
5
19
2.66
1.22
1.2
1.0
1691.50
1473.05
miu/ml
—
5
19
6
26
2.33
1.19
1.0
1.2
—
—
—
0
0
51
391
1.37
1.18
1.4
1.5
285.71
497.83
titre
—
7
83
10
50
2.03
1.18
1.4
2.4
3.24
5.15
u/ml
—
10
50
34
243
1.45
1.16
7.9
11.3
7.40
7.42
ph
0.56
20
131
31
218
1.47
1.15
13.0
9.9
25.37
24.90
mmol/l
0.40
31
218
19
119
1.64
1.14
3.7
8.1
—
—
—
0
0
12
66
1.85
1.10
4.5
2.3
7.43
7.42
ph
0.45
12
66
5
21
2.40
1.09
1.4
1.0
—
—
—
0
0
99
842
1.26
1.08
4.2
3.4
26.41
32.59
ng/l
0.30
67
524
7
33
2.15
1.06
1.3
3.9
—
—
—
0
0
10
53
1.92
1.02
5.8
3.9
—
—
—
0
0
41
314
1.35
0.97
2.1
1.6
—
—
—
0
0
16
101
1.62
0.95
4.3
4.4
37.01
36.95
°c
0.43
16
101
6
27
2.25
0.94
1.3
3.3
49.50
55.73
%
—
6
22
267
2565
1.37
0.93
17.5
13.7
25.76
22.25
mg/l
0.85
231
2041
6
28
2.17
0.92
1.5
1.4
—
—
—
0
0
11
63
1.77
0.91
2.6
1.5
0.24
0.41
nmol/l
1.02
11
52
14
87
1.64
0.89
1.6
1.3
—
89.00
—
0
10
6
30
2.02
0.87
1.3
1.1
—
—
—
0
0
54
438
1.28
0.87
3.5
2.7
131.30
101.65
ug/g
0.53
48
341
37
471
0.76
0.84
1.9
1.8
—
—
—
0
0
41
322
1.32
0.83
1.8
3.1
4.27
5.78
e9/l
0.63
35
289
22
157
1.43
0.79
1.3
1.2
—
—
—
0
0
18
124
1.48
0.77
1.5
5.3
0.77
0.60
%
1.02
18
124
5
25
2.02
0.73
1.2
1.0
—
—
—
0
0
7
39
1.81
0.73
1.7
1.2
27.76
17.99
u/l
—
7
34
9
144
0.61
0.71
1.1
1.1
—
—
—
0
0
18
249
0.71
0.70
1.6
1.6
835.55
935.72
mu/l
0.26
18
212
5
93
0.53
0.68
1.2
2.0
—
—
—
0
0
5
28
1.80
0.66
1.0
1.1
—
—
—
0
0
111
999
1.18
0.66
3.6
3.3
21.74
0.00
estimate
0.48
23
229
26
200
1.33
0.63
2.7
2.2
6.24
6.12
ph
0.22
19
128
33
264
1.28
0.61
1.6
1.4
—
—
—
0
0
238
2285
1.20
0.61
4.1
3.9
1.17
1.26
mmol/l
1.47
227
2144
0
20
0.00
0.60
0.0
1.2
—
35.10
—
0
15
250
2412
1.22
0.60
4.7
4.5
1.48
1.46
mmol/l
0.25
237
2269
233
2236
1.19
0.58
5.8
5.5
37.64
38.09
mmol/mol
0.37
225
2120
29
230
1.29
0.58
1.4
1.2
68.99
155.21
u/ml
—
8
86
13
90
1.46
0.56
1.2
1.2
—
—
—
0
0
30
242
1.27
0.53
9.2
10.0
—
—
—
0
0
14
100
1.42
0.53
2.6
1.8
—
—
—
0
0
107
976
1.15
0.52
2.1
2.0
95.11
97.25
pmol/l
0.22
63
495
252
2442
1.20
0.52
5.1
5.0
2.74
2.77
mmol/l
0.19
243
2303
128
1185
1.14
0.50
13.1
10.7
0.00
0.00
e9/l
0.72
104
942
7
110
0.63
0.49
1.3
1.3
—
5.28
—
0
5
7
46
1.53
0.48
1.3
1.2
—
—
—
0
0
85
768
1.15
0.47
3.5
2.9
9.26
0.00
estimate
0.49
27
222
79
710
1.15
0.47
2.9
3.1
0.45
0.36
e6/l
0.18
57
506
7
48
1.47
0.47
2.7
3.5
3.65
3.90
e9/l
—
7
48
18
138
1.32
0.46
3.4
2.6
37.11
38.18
u/ml
0.02
18
133
12
86
1.41
0.45
1.3
1.3
—
—
—
0
0
49
426
1.18
0.44
2.0
1.7
412.73
447.89
pmol/l
0.51
44
370
5
31
1.62
0.43
1.0
1.3
—
—
—
0
0
38
324
1.20
0.43
1.9
1.7
1339.49
1219.91
nmol/l
0.20
33
241
11
150
0.72
0.42
1.6
1.6
63.58
59.41
ug/l
0.17
11
126
13
96
1.37
0.42
1.5
1.7
8.22
6.05
u/ml
—
5
23
0
16
0.00
0.41
0.0
1.2
—
0.51
—
0
8
211
2032
1.13
0.41
4.6
4.3
14.59
14.63
pmol/l
0.08
193
1886
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
97
1046
0.89
0.38
2.1
1.9
1.39
1.37
mmol/l
0.10
91
913
9
67
1.35
0.38
1.0
1.0
—
—
—
0
0
99
1066
0.89
0.38
3.0
2.8
—
—
—
0
0
17
134
1.28
0.38
1.2
1.1
1.01
0.91
g/l
0.76
17
134
66
597
1.14
0.37
3.4
3.3
1.02
1.02
kg/l
0.07
45
381
20
162
1.25
0.36
1.0
1.1
—
—
—
0
0
249
2429
1.15
0.36
4.8
4.6
4.63
4.67
mmol/l
0.27
241
2300
6
41
1.47
0.36
1.3
1.7
—
—
—
0
0
6
41
1.47
0.36
1.3
1.7
—
—
—
0
0
6
41
1.47
0.36
1.3
1.7
—
—
—
0
0
6
41
1.47
0.36
1.3
1.7
—
—
—
0
0
6
41
1.47
0.36
2.3
2.0
4.12
4.63
mmol/24h
—
6
35
88
815
1.11
0.33
3.3
3.3
28.85
119.11
e6/l
0.56
65
607
21
174
1.22
0.32
1.4
1.3
—
37.15
—
0
12
19
158
1.22
0.29
1.6
1.4
0.59
0.30
mg/l
—
9
64
76
705
1.10
0.28
3.4
3.5
0.00
0.00
estimate
0.50
24
257
12
94
1.29
0.28
1.5
1.2
—
—
—
0
0
20
168
1.20
0.28
4.4
3.4
1.21
1.23
mmol/l
1.08
20
140
27
309
0.86
0.27
1.4
1.8
—
—
—
0
0
30
263
1.16
0.27
1.5
1.5
—
—
—
0
0
16
132
1.22
0.26
1.0
1.1
1.55
1.54
g/l
0.05
16
132
29
329
0.87
0.26
1.3
1.3
—
—
—
0
0
72
670
1.10
0.25
1.8
2.1
245.72
298.85
u/l
0.17
67
640
29
255
1.15
0.25
1.7
1.9
3.41
3.54
mmol/l
0.25
22
191
12
96
1.26
0.25
3.7
2.2
—
—
—
0
0
142
1365
1.08
0.23
4.0
3.6
34.48
0.02
estimate
0.49
29
254
16
134
1.20
0.23
6.3
2.8
—
—
—
0
0
5
38
1.32
0.23
2.8
1.4
26.20
21.31
ng/l
—
5
38
5
39
1.29
0.23
3.2
2.0
—
—
—
0
0
5
40
1.25
0.22
1.2
1.6
—
—
—
0
0
26
293
0.88
0.22
1.3
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
2.3
—
511.80
—
0
5
0
11
0.00
0.21
0.0
1.1
—
0.78
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.7
—
3.15
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
20
173
1.17
0.21
1.4
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.1
—
637.40
—
0
5
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
270
2667
1.12
0.20
16.5
11.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.5
—
0.00
—
0
14
70
660
1.08
0.19
1.6
1.6
19.20
21.65
nmol/l
0.75
65
567
45
416
1.10
0.19
2.7
3.0
1.04
2.73
e6/l
2.31
20
196
12
100
1.21
0.18
8.3
8.1
1.34
1.21
mg/l
0.30
12
94
22
195
1.14
0.18
1.7
1.6
1.10
1.32
g/l
0.41
22
185
32
292
1.11
0.17
1.4
1.5
—
—
—
0
0
8
68
1.18
0.16
1.6
1.1
—
—
—
0
0
8
68
1.18
0.16
1.6
1.1
—
—
—
0
0
21
187
1.13
0.16
3.3
2.6
0.50
0.68
e6/l
0.13
21
180
8
73
1.10
0.16
2.1
1.8
188.75
232.34
pmol/l
—
8
67
9
81
1.11
0.15
1.3
1.3
—
—
—
0
0
83
796
1.06
0.14
3.5
3.2
7.44
8.38
mmol/l
0.99
74
687
236
2329
1.06
0.13
4.9
4.3
5.75
5.77
mmol/l
0.08
220
2155
139
1354
1.05
0.13
3.9
3.5
0.00
6.04
estimate
0.50
28
269
18
200
0.89
0.13
1.3
1.8
—
—
—
0
0
16
143
1.13
0.11
1.2
2.2
—
—
—
0
0
137
1338
1.04
0.11
3.9
3.5
0.00
0.00
estimate
-0.00
30
269
68
705
0.95
0.10
4.2
2.7
—
—
—
0
0
20
216
0.92
0.08
1.3
1.8
—
—
—
0
0
13
144
0.90
0.08
1.1
1.4
228.44
289.01
miu/ml
—
6
75
5
61
0.82
0.08
2.6
2.0
—
—
—
0
0
5
63
0.79
0.08
1.0
2.6
—
—
—
0
0
239
2369
1.04
0.08
5.6
5.2
1.67
1.83
mu/l
2.32
224
2217
20
215
0.93
0.08
1.3
1.8
—
—
—
0
0
6
72
0.83
0.07
1.3
1.3
—
—
—
0
0
8
75
1.07
0.07
2.9
2.9
58.50
56.52
%
—
8
75
50
482
1.04
0.07
1.6
1.6
—
—
—
0
0
7
85
0.82
0.07
2.1
1.5
—
—
—
0
0
11
122
0.90
0.07
1.6
1.6
—
—
—
0
0
69
671
1.04
0.07
4.5
4.1
14.93
7.81
mg/mmol
0.38
44
421
44
424
1.04
0.06
1.6
1.6
—
—
—
0
0
20
213
0.93
0.06
1.3
1.8
—
—
—
0
0
18
168
1.08
0.06
1.7
2.3
32.40
7969.56
u/l
—
5
60
11
121
0.91
0.06
1.5
1.5
—
—
—
0
0
46
475
0.96
0.05
1.3
1.3
2.73
8.09
u/ml
1.32
21
181
73
714
1.03
0.05
4.6
3.8
7.39
7.39
ph
0.23
51
484
31
323
0.96
0.05
2.7
2.7
0.62
0.77
ug/l
0.83
18
177
13
120
1.09
0.05
2.1
1.9
9.32
8.16
u/l
0.10
13
93
20
211
0.94
0.04
1.3
1.8
—
—
—
0
0
16
150
1.07
0.04
1.2
1.4
—
—
—
0
0
11
119
0.92
0.04
1.5
1.5
1.24
1.31
mm
0.31
11
87
14
131
1.07
0.03
1.2
2.0
—
—
—
0
0
17
161
1.06
0.03
1.8
1.7
—
—
—
0
0
16
169
0.94
0.03
1.3
1.9
—
—
—
0
0
11
102
1.08
0.03
1.1
1.2
0.11
2.41
u/ml
—
6
61
112
1108
1.02
0.03
3.6
3.2
6.28
6.18
ph
0.41
71
598
67
661
1.02
0.02
4.0
3.4
67.44
47.48
mg/l
0.29
44
433
44
448
0.98
0.01
3.6
3.3
24.26
271.71
ng/l
2.29
32
305
51
518
0.98
0.01
1.4
1.3
10.40
21.60
iu/ml
2.41
17
147
77
762
1.01
0.01
2.1
2.1
—
—
—
0
0
61
617
0.99
0.01
1.8
1.7
—
—
—
0
0
97
963
1.01
0.01
4.1
4.0
60.91
73.45
e6/l
0.19
66
649
86
854
1.01
0.00
1.5
1.6
—
—
—
0
0
12
122
0.98
0.00
1.6
2.4
1.18
6.21
iu/ml
—
5
26
21
208
1.01
0.00
2.9
3.3
—
—
—
0
0
72
725
0.99
0.00
1.5
1.4
2.03
2.28
g/l
0.85
45
433
0
9
0.00
-0.00
0.0
13.2
—
8.54
—
0
9
0
6
0.00
-0.00
0.0
1.3
—
5.90
—
0
6
0
8
0.00
-0.00
0.0
2.1
—
15.05
—
0
8
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
2.07
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
86
0.93
-0.00
1.1
1.2
—
—
—
0
0
5
56
0.89
-0.00
1.2
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
56.25
—
0
8
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
72
0.97
-0.00
5.6
7.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.0
—
45.67
—
0
6
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
58
0.86
-0.00
1.2
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
35.27
—
0
8
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
6.20
—
0
5
0
6
0.00
-0.00
0.0
6.0
—
—
—
0
0
6
68
0.88
-0.00
13.3
3.4
166.05
27.39
mg/l
—
6
59
0
5
0.00
-0.00
0.0
1.0
—
57.60
—
0
5
79
790
1.00
-0.00
1.5
1.5
6.88
1.31
u/ml
0.47
21
190
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
3.68
—
0
5
0
6
0.00
-0.00
0.0
2.5
—
3.17
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
68
0.88
-0.00
13.3
3.4
26.53
35.38
mg/l
—
6
59
0
6
0.00
-0.00
0.0
1.0
—
0.02
—
0
6

Mortality – FinRegistry

Association

Association between endpoint CD2_BENIGN_LYMPHANGIOMA and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_LYMPHANGIOMA 1.448 [1.07, 1.96] 0.017
Birth year 0.992 [0.98, 1.0] 0.092

During the follow-up period (1.1.1998 — 31.12.2019), 67 out of 980 females with CD2_BENIGN_LYMPHANGIOMA died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_LYMPHANGIOMA 1.548 [1.15, 2.08] 0.004
Birth year 0.985 [0.97, 1.0] 0.007

During the follow-up period (1.1.1998 — 31.12.2019), 77 out of 1096 males with CD2_BENIGN_LYMPHANGIOMA died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_LYMPHANGIOMA.

N-year risk Females Males
1 0.107% 0.272%
5 0.651% 1.425%
10 1.786% 3.827%
15 3.482% 7.045%
20 6.277% 12.193%

Relationships between endpoints

Index endpoint: CD2_BENIGN_LYMPHANGIOMA – Lymphangioma, anys site

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data